Edwards Lifesciences has claimed an FDA approval for its Sapien M3 transcatheter mitral valve replacement system—marking the ...

First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first ...

The US Food and Drug Administration has approved the Sapien M3 system for transseptal transcatheter mitral valve replacement (TMVR) for use in patients with symptomatic moderate-to-severe mitral ...

Edwards Lifesciences (EW) announced on Tuesday that the U.S. Food and Drug Administration approved its SAPIEN M3 ...

Edwards Lifesciences (EW) announced its SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal ...

Mitral valve disease occurs when the mitral valve doesn’t work properly, allowing blood to flow backward into the left atrium. As a result, your heart does not pump enough blood out of the left ...

The Sechenov University Cardiovascular Surgery Clinic has developed a program that will help cardiac surgeons with mitral valve reconstruction. The difficulty lies in the fact that no one has done a ...

Affluent Medical recently announced agreements to acquire Caranx Medical and Artedrone to form a new medtech company called ...

Mitral valve stenosis is a form of valvular heart disease. It occurs when there is a narrowing of the mitral valve, which restricts the flow of blood from the left atrium to the left ventricle. Mitral ...